Skip to Content
Merck

21223

Hydroxyapatite

purum p.a., ≥90% (as Ca3(PO4)2, KT)

Synonym(s):

Calcium phosphate hydroxide, Durapatite, Hydroxylapatite

Sign In to View Organizational & Contract Pricing.

Select a Size

1 KG

$300.00

$300.00


Please contact Customer Service for Availability

Request a Bulk Order

About This Item

Linear Formula:
3Ca3(PO4)2 · Ca(OH)2
CAS Number:
Molecular Weight:
502.31
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12352300
EC Number:
215-145-7
MDL number:
Assay:
≥90% (as Ca3(PO4)2, KT)
Form:
powder

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Hydroxyapatite, purum p.a., ≥90% (as Ca3(PO4)2, KT)

InChI key

XYJRXVWERLGGKC-UHFFFAOYSA-D

InChI

1S/5Ca.3H3O4P.H2O/c;;;;;3*1-5(2,3)4;/h;;;;;3*(H3,1,2,3,4);1H2/q5*+2;;;;/p-10

SMILES string

[Ca++].[Ca++].[Ca++].[Ca++].O[Ca+].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O

grade

purum p.a.

assay

≥90% (as Ca3(PO4)2, KT)

form

powder

impurities

≤5% water (KFT)

loss

≤10% loss on ignition, 800 °C

anion traces

chloride (Cl-): ≤500 mg/kg
sulfate (SO42-): ≤2000 mg/kg

cation traces

Cd: ≤5 mg/kg
Co: ≤5 mg/kg
Cu: ≤20 mg/kg
Fe: ≤400 mg/kg
Ni: ≤5 mg/kg
Pb: ≤5 mg/kg
Zn: ≤10 mg/kg

Quality Level

Looking for similar products? Visit Product Comparison Guide

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
900203677418289396
form

powder

form

powder

form

nanopowder, solid

form

powder, solid

assay

≥90% (as Ca3(PO4)2, KT)

assay

-

assay

≥97%

assay

-

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

grade

purum p.a.

grade

-

grade

-

grade

-

impurities

≤5% water (KFT)

impurities

-

impurities

-

impurities

-

cation traces

Cd: ≤5 mg/kg, Cu: ≤20 mg/kg, Ni: ≤5 mg/kg, Zn: ≤10 mg/kg, Co: ≤5 mg/kg, Pb: ≤5 mg/kg, Fe: ≤400 mg/kg

cation traces

-

cation traces

-

cation traces

-

Application

Hydroxyapatite may be used in the preparation of bioceramic specimens by incorporation of a small amount of silicon (0.4wt%) into the structure of hydroxyapatite.[1] It may be used for the preparation of porous microstructures, having important prosthetic applications.[2]

General description

Bone and tooth implant materials have been prepared from polycrystalline hydroxyapatite. The compressive, flexural, torsional and dynamic torsional strengths of polycrystalline hydroxyapatite were investigated.[3] Electrophoretic deposition of hydroxyapatite on to flat titanium plate material has been studied.[3][2]
Hydroxyapatite is a bioceramic mainly found in minerals of bone and teeth.[4] Due to its high biocompatibility and similarity with inorganic components found in hard tissues, it is mainly used to produce biocomposites and prostheses for bones and teeth replacement.[5]

Storage Class

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Hydroxyapatite synthesis and the benefits of its blend with calcium aluminate cement.
Oliveira IR, et al.
Ceramics International, 42(2), 2542-2549 (2016)
Mechanical properties of sintered hydroxyapatite for prosthetic applications.
Akao M ,et al.
J. Mater. Sci., 16(3), 809-812 (1981)
Chemical characterization of silicon-substituted hydroxyapatite
Gibson I, et al.
Journal of Biomedical Materials Research, 44(4), 422-428 (1999)
P Ducheyne et al.
Biomaterials, 7(2), 97-103 (1986-03-01)
Hydroxyapatite from two sources was electrophoretically deposited onto flat titanium plate material. Depending upon the deposition conditions various changes in the structure of the ceramic were identified. A well-adhering Ti-P compound was present at the interface. Hydroxyapatite oxygenated to various
Sophie E P New et al.
Circulation research, 113(1), 72-77 (2013-04-26)
We previously showed that early calcification of atherosclerotic plaques associates with macrophage accumulation. Chronic renal disease and mineral imbalance accelerate calcification and the subsequent release of matrix vesicles (MVs), precursors of microcalcification. We tested the hypothesis that macrophage-derived MVs contribute

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service